Kairos Pharma Ltd.

0.94
0.02 (2.02%)
At close: Mar 31, 2025, 3:42 PM
0.96
2.52%
After-hours: Mar 31, 2025, 08:00 PM EDT

Kairos Pharma Ltd. Balance Sheet Statement

Year FY23 FY22 FY21 FY20
Cash & Equivalents 93K 437K 73K 14.31K
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a
Other Long-Term Assets 482K 57K n/a n/a
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 8K n/a n/a n/a
Total Current Assets 101K 437K 73K 14.31K
Property-Plant & Equipment n/a n/a n/a n/a
Goodwill & Intangibles 382K 542K 702K n/a
Total Long-Term Assets 864K 599K 702K n/a
Total Assets 965K 1.04M 775K 14.31K
Account Payables 1.59M 1.63M 1.55M 307.15K
Deferred Revenue n/a n/a n/a n/a
Short-Term Debt n/a n/a 380K 50K
Other Current Liabilities n/a 4K 14K n/a
Total Current Liabilities 1.59M 1.63M 1.94M 357.15K
Long-Term Debt n/a 582K n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a
Total Long-Term Liabilities n/a 582K n/a n/a
Total Liabilities 1.59M 2.21M 1.94M 357.15K
Total Debt n/a 582K 380K 50K
Common Stock 11K 10K 10K 192.39K
Retained Earnings -6.32M -4.4M -3.35M -1.2M
Comprehensive Income n/a n/a n/a n/a
Shareholders Equity -626K -1.18M -1.17M -342.84K
Total Investments n/a n/a n/a n/a